NCT05396170 (NOSFERATU) is a clinical trial of phlebotomy in Polycythemia, sponsored by Leiden University Medical Center.

Who is sponsoring NCT05396170?

NCT05396170 is sponsored by Leiden University Medical Center.

What drugs are being tested in NCT05396170?

Interventions in NCT05396170: phlebotomy.

What condition does NCT05396170 study?

NCT05396170 studies Polycythemia.

Is NCT05396170 still recruiting?

NCT05396170 is currently recruiting now. Last updated 13 November 2024.

Last reviewed 2024-11-13 · How we verify

NCT05396170: NOSFERATU

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Phlebotomy on Heartrate in Polycythemia Patients

Recruiting now Last updated 13 November 2024

What this trial tests

trial testing phlebotomy in Polycythemia in 10 participants. Currently enrolling.

Timeline

21 July 2022

Primary endpoint
31 December 2024

1 January 2025

Quick facts

Lead sponsor	Leiden University Medical Center
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	10
Start date	21 July 2022
Primary completion	31 December 2024
Estimated completion	1 January 2025
Sites	1 location across Netherlands

Drugs / interventions tested

phlebotomy

Conditions studied

Polycythemia — all drugs for Polycythemia →

Sponsor

Leiden University Medical Center

Who can join

18 and older, any sex, with Polycythemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Single-centre, observational within-subject design: patients that undergo phlebotomies regularly for polycythemia will be measured continuously by wearables one week before until one week after a phlebotomy, for three phlebotomies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of phlebotomy

Trials testing the same drug.

NCT05064267 — Hemostatic Profiles in Pediatric CKD · completed
NCT00507702 — Identification of Key Blood Molecular Markers for Immunotherapy · terminated

Other recruiting trials for Polycythemia

Currently open trials in the same condition.

NCT06038630 — 129Xe MRI Cardiopulmonary · Phase 2 · recruiting

Other Leiden University Medical Center trials

Trials by the same sponsor.

NCT07312565 — Occurrence of Abdominal Aortic Aneurysms in Patients With Aneurysmal Subarachnoid Hemorrhage · not yet recruiting
NCT07090343 — Semaglutide in Patients Undergoing Transcatether Aortic Valve Replacement · Phase 3 · not yet recruiting
NCT07498738 — Making Diabetes Care Fit for Young Adults Living With Type 1 Diabetes: Observations, Reflections and Expert Opinions · NA · not yet recruiting
NCT06545292 — Microsampling for Therapeutic Drug Monitoring of Oral Oncolytics in Oncology Patients · NA · recruiting
NCT07021495 — SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY) · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05396170 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Leiden University Medical Center
Last refreshed: 13 November 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05396170.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing